Skewed X chromosome inactivation and breast and ovarian cancer status : evidence for X-linked modifiers of BRCA1
Lose, Felicity, Duffy, David L., Kay, Graham F., Cuningham, Kathleen, Kedda, Mary A., & Spurdle, Amanda B. (2008) Skewed X chromosome inactivation and breast and ovarian cancer status : evidence for X-linked modifiers of BRCA1. Journal of the National Cancer Institute, 100(21), pp. 1519-1529.
Background: X chromosome inactivation, which silences gene expression from one of the two X chromosomes in
females, is usually random. Skewed X inactivation has been implicated in both the expression and the
suppression of X-linked disease phenotypes and has been reported to occur more frequently in breast and
ovarian cancer patients, including BRCA1 or BRCA2 mutation carriers, than in control subjects.-----
Methods: We assessed the pattern of X chromosome inactivation using methylation-specific polymerase chain reaction
amplification of the exon 1 microsatellite region of the X-linked androgen receptor ( AR ) gene in DNA
from blood samples obtained from control subjects without a personal history of breast or ovarian cancer
(n = 735), ovarian cancer patients (n = 313), familial breast cancer patients who did not carry mutations in
BRCA1 or BRCA2 (n = 235), and affected and unaffected carriers of mutations in BRCA1 (n = 260) or BRCA2
(n = 63). We defined the pattern of X chromosome inactivation as skewed when the same X chromosome
was active in at least 90% of cells. The association between skewed X inactivation and disease and/or
BRCA mutation status was assessed by logistic regression analysis. The association between skewed X
inactivation and age at cancer diagnosis was assessed by Cox proportional hazards regression analysis.
All statistical tests were two-sided.-----
Results: The age-adjusted frequency of skewed X inactivation was not statistically significantly higher in ovarian
cancer or familial breast cancer case subjects compared with control subjects. Skewed X inactivation was
higher in BRCA1 mutation carriers than in control subjects (odds ratio [OR] = 2.7, 95% confidence interval
[CI] = 1.1 to 6.2; P = .02), particularly among unaffected women (OR = 6.1, 95% CI = 1.5 to 31.8; P = .005).
Among BRCA1 mutation carriers, those with skewed X inactivation were older at diagnosis of breast or
ovarian cancer than those without skewed X inactivation (hazard ratio [HR] of breast or ovarian cancer =
0.37, 95% CI = 0.14 to 0.95; P = .04). Among BRCA2 mutation carriers, skewed X inactivation also occurred
more frequently in unaffected carriers than in those diagnosed with breast or ovarian cancer (OR = 5.2,
95% CI = 0.5 to 28.9; P = .08) and was associated with delayed age at onset (HR = 0.59, 95% CI = 0.37 to
0.94; P = .03).-----
Conclusions: Skewed X inactivation occurs at an increased frequency in BRCA1 (and possibly BRCA2 ) mutation carriers
compared with control subjects and is associated with a statistically significant increase in age at diagnosis
of breast and ovarian cancer.
Citation countsare sourced monthly fromand citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health|
Current > Institutes > Institute of Health and Biomedical Innovation
Current > Schools > School of Public Health & Social Work
|Deposited On:||15 Jun 2009 14:47|
|Last Modified:||11 Aug 2011 01:44|
Repository Staff Only: item control page